3Z Pharmaceuticals
PrivateLast Round
Grant
Dec 2, 2025
Total Funding Raised
$800,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
3Z Pharmaceuticals operates in Healthcare & Life Sciences and is based in Iceland. Its latest recorded funding round was a Grant round in December 2025.
3Z Pharmaceuticals is a biotechnology company that develops novel candidates for central nervous system disorders by utilizing advanced disease modeling and behavioral genetics techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3Z Pharmaceuticals Comparables
Compare 3Z Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZeClinics | 85% | |
| Creative Biostructure | 83% | |
| Pentagrit | 82% |
For institutional investors. Book with your work email.
3Z Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2025 | ||||
| Grant | Oct 1, 2025 | ||||
| VC Round | Jun 20, 2022 | ||||
| Seed | Jul 5, 2016 | ||||
| Seed | Mar 26, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
3Z Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rannís - The Icelandic Centre for Research | Grant |
| Eurostars SME programme | Grant |
| NSA Ventures | Seed |
| Nýsköpunarsjóðurinn Kría | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 44% MoM.
- Apr 21, 2026
Monthly visitors increased 670% MoM, reaching 5.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 16, 2026
3z receives a $411K grant from Iceland’s Technology Development Fund to advance its ADHD research in Iceland on Oct 16th '26.
- partners_withOct 16, 2026
3z and ariadne.ai ag work together on SPADE, a two-year Eurostars project that uses spatial transcriptomics to map where ADHD drug candidate 3Z-20-003 acts in the brain, in Iceland on Oct 16th '26.
For institutional investors. Book with your work email.
3Z Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 3Z Pharmaceuticals's valuation, stock price, and market status.
Is 3Z Pharmaceuticals a public or private company?
3Z Pharmaceuticals is a private company.
What is the current stock price of 3Z Pharmaceuticals?
3Z Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks 3Z Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 3Z Pharmaceuticals worth (valuation)?
Valuation information for 3Z Pharmaceuticals is not publicly available.
Can I buy 3Z Pharmaceuticals stock?
3Z Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 3Z Pharmaceuticals's last funding round?
3Z Pharmaceuticals's most recent funding round was Grant on December 2, 2025.
Who are the main investors in 3Z Pharmaceuticals?
Key investors in 3Z Pharmaceuticals include Nýsköpunarsjóðurinn Kría.
Will 3Z Pharmaceuticals IPO soon?
No public IPO plans have been announced for 3Z Pharmaceuticals.
How can I track 3Z Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in 3Z Pharmaceuticals's shares on secondary markets.